PLAT and stroke disorder: Even in embolic stroke treated with tissue plasminogen activator (tPA), where MMP-9 activation has been associated with increased hemorrhagic transformation (HT) and worsened outcomes in animals [23, 24] and humans [25, 26], we have shown candesartan to be acutely vascular protective [22].